Ott Laius
Impact in
- Family Practice top 10%
- Medication Adherence and Compliance
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Economic and Financial Impacts of Cancer
Papers in
-
- Pharmacological Effects and Toxicity Studies 3
- Pharmaceutical studies and practices 2
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Pharmaceutical Economics and Policy 2
- Co-authors
- Kristina Garuolienè (4 shared papers)Catherine Sermet (4 shared papers)Brian Godman (4 shared papers)Lars L. Gustafsson (4 shared papers)Marija Kalaba (3 shared papers)Corrine Zara (3 shared papers)Harald Herholz (2 shared papers)Alan Haycox (2 shared papers)
In The Last Decade
Ott Laius
20 papers receiving 402 citations
Peers
Comparison fields: 5 of 70
- Family Practice 18
- Economics and Econometrics 239
- Pharmacology 42
- Geriatrics and Gerontology 12
- Pediatrics, Perinatology and Child Health 62
Countries citing papers authored by Ott Laius
This map shows the geographic impact of Ott Laius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ott Laius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ott Laius more than expected).
Fields of papers citing papers by Ott Laius
This network shows the impact of papers produced by Ott Laius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ott Laius. The network helps show where Ott Laius may publish in the future.
Co-authors
The 25 scholars most cited alongside Ott Laius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 198 | |
| 2 | 2010 | 73 | |
| 3 | 2012 | 37 | |
| 4 | Correspondencesharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers | 2010 | 23 |
| 5 | 2020 | 13 | |
| 6 | 2018 | 11 | |
| 7 | 2017 | 10 | |
| 8 | 2019 | 7 | |
| 9 | 2016 | 6 | |
| 10 | 2017 | 6 | |
| 11 | 2020 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2017 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2016 | 4 | |
| 18 | 2021 | 2 | |
| 19 | 2021 | 1 | |
| 20 | 2014 | 1 |
About Ott Laius
Ott Laius is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics, Family Practice, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 23 papers that have together received 419 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Medication Adherence and Compliance (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Acne and Rosacea Treatments and Effects (2 papers), Bone health and osteoporosis research (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Pharmaceutical Economics and Policy (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Family Practice (18 citations), Economics and Econometrics (239 citations), Pharmacology (42 citations), Geriatrics and Gerontology (12 citations) and Pediatrics, Perinatology and Child Health (62 citations). Ott Laius has collaborated with scholars based in Estonia, Lithuania and Finland. Frequent co-authors include Kristina Garuolienè, Catherine Sermet, Brian Godman, Lars L. Gustafsson, Marija Kalaba, Corrine Zara, Harald Herholz, Alan Haycox, Silvio Garattini and Saira Jan. Their work appears in journals such as Archives of Osteoporosis, Research in Social and Administrative Pharmacy, Experimental Biology and Medicine, Journal of Medical Internet Research and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.